Antipsychotic Dosing in Preclinical Models Is Often Unrepresentative of the Clinical Condition: A Suggested Solution Based on in Vivo Occupancy

10.1097/00007691-199706000-00011

Arnt, 1997, Differentiation of classical and novel antipsychotics using animal models., Int Clin Psychopharmacol, 12 (Suppl 1), S9, 10.1097/00004850-199702001-00003

Baldessarini, 1993, Tissue concentrations of clozapine and its metabolites in the rat., Neuropsychopharmacology, 9, 117, 10.1038/npp.1993.50

Bezchlibnyk-Butler KZ Jeffries JJ (1999) Clinical Handbook of Psychotropic Drugs. (Hogrefe & Huber Publishers, Toronto).

Bressan, 2001, Dopamine D(2) receptor blockade in schizophrenia., Am J Psychiatry, 158, 971, 10.1176/appi.ajp.158.6.971-a

Burki, 1986, Effects of fluperlapine on dopaminergic systems in rat brain., Psychopharmacology, 89, 77, 10.1007/BF00175194

10.1016/0024-3205(80)90002-8

10.1002/bdd.2510130106

10.1080/10673220216279

10.1001/archpsyc.1988.01800250087012

10.1007/s002130100790

10.1016/S0006-3223(01)01251-3

Kapur, 2000, Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the bench., Can J Psychiatry, 45, 241, 10.1177/070674370004500302

10.1176/appi.ajp.157.4.514

10.1001/archpsyc.57.6.553

Kapur, 1999, Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone and olanzapine in schizophrenia., Am J Psychiatry, 156, 286, 10.1176/ajp.156.2.286

10.1016/S0893-133X(00)00137-8

10.1007/s002130050020

10.1006/nimg.2001.0879

Rowland M Tozer TN (1995) Clinical Pharmacokinetics: Concepts and Applications. (Lippincott Williams & Wilkins, Philadelphia).

10.1007/BF02244923

10.1159/000026566

10.1007/BF02245606

10.2165/00023210-200115090-00001

10.1007/BF02245444

10.1007/s002130000466

10.1007/s002130050834